Arkadios Wealth Advisors Biogen Inc. Transaction History
Arkadios Wealth Advisors
- $3.16 Billion
- Q2 2025
A detailed history of Arkadios Wealth Advisors transactions in Biogen Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 3,003 shares of BIIB stock, worth $431,410. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,003
Previous 3,354
10.47%
Holding current value
$431,410
Previous $458,000
17.69%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding BIIB
# of Institutions
1,021Shares Held
131MCall Options Held
2.84MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.48 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.27 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.09 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.07 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$689 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...